Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ventas Reports 13 Percent Increase in 1st Quarter 2013 Normalized FFO to $1.03 Per Diluted Share

VTR
Ventas Reports 13 Percent Increase in 1st Quarter 2013 Normalized FFO to $1.03 Per Diluted Share

2013 Normalized FFO Per Diluted Share Guidance of $3.99 to $4.07 Reaffirmed

Ventas, Inc. (NYSE: VTR) (“Ventas” or the “Company”) said today that normalized Funds From Operations (“FFO”) for the quarter ended March 31, 2013 increased 14.3 percent to $301.6 million, from $263.9 million for the comparable 2012 period. Normalized FFO per diluted common share was $1.03 for the quarter ended March 31, 2013, a 13 percent increase from $0.91 for the comparable 2012 period. Weighted average diluted shares outstanding for the quarter rose by one percent to 293.9 million, compared to 290.8 million in the first quarter of 2012.

“We are pleased to report that we have sustained excellent results, delivering consistent superior performance to stakeholders,” Ventas Chairman and Chief Executive Officer Debra A. Cafaro said. “Our high-quality and diverse portfolio, our team and our accretive investments all contributed to outstanding FFO and same-store property NOI growth, as well as the increase in our 2013 dividend,” she added. “Our powerful platform, financial strength and liquidity have built a company with an enterprise value exceeding $31 billion that produced total return to shareholders of more than 22 percent year to date and 888 percent over the last decade. We are excited about our future opportunities.”

The growth in first quarter 2013 normalized FFO per diluted common share compared to the first quarter of 2012 is due primarily to the Company’s $2.7 billion of investments in 2012; net operating income increases in its high-quality private pay seniors housing communities managed by Atria Senior Living, Inc. (“Atria”) and Sunrise Senior Living, LLC (“Sunrise”), its triple-net lease portfolio and its medical office building (“MOB”) segment; and lower weighted average interest rates. These benefits were partially offset by higher debt balances, increases in general and administrative expenses, asset sales and loan repayments in 2013 and 2012, and an increase in weighted average diluted shares outstanding.

Normalized FFO for the quarter ended March 31, 2013 excludes the net expense (totaling $6.3 million, or $0.02 per diluted share) from merger-related expenses and deal costs (including integration costs), amortization of other intangibles and non-cash income tax expense. Normalized FFO for the quarter ended March 31, 2012 excluded the net expense (totaling $49.1 million, or $0.17 per diluted share) from loss on extinguishment of debt, non-cash income tax expense, merger-related expenses and deal costs (including integration costs), and amortization of other intangibles.

Net income attributable to common stockholders for the quarter ended March 31, 2013 was $112.2 million, or $0.38 per diluted common share, including discontinued operations of $(5.6) million. Net income attributable to common stockholders for the quarter ended March 31, 2012 was $90.6 million, or $0.31 per diluted common share, including discontinued operations of $43.4 million. This $21.6 million increase in net income attributable to common stockholders in the first quarter of 2013 over the prior year comparable period is primarily the result of the increases described above for normalized FFO, changes in losses on extinguishment of debt and income taxes, partially offset by year-over-year changes in discontinued operations and additional depreciation and amortization.

FFO, as defined by the National Association of Real Estate Investment Trusts (“NAREIT”), for the quarter ended March 31, 2013 increased 37.5 percent to $295.3 million, from $214.8 million in the comparable 2012 period. NAREIT FFO per diluted common share for the quarter ended March 31, 2013 increased 35.1 percent to $1.00, from $0.74 in the first quarter of 2012.

PRIVATE PAY SENIORS HOUSING OPERATING PORTFOLIO

First Quarter 2013 Same-Store NOI Grows 7.3 Percent and Occupancy Rises 270 Basis Points

At March 31, 2013, the Company’s seniors housing operating portfolio included 220 communities: 125 seniors housing communities managed by Atria and 95 seniors housing communities managed by Sunrise. First quarter 2013 Net Operating Income (“NOI”) after management fees for this portfolio totaled $108.1 million.

For the 195 private pay seniors housing communities owned by the Company for the full first quarters of 2013 and 2012 (“same-store”), average unit occupancy rose 270 basis points to 91.1 percent, NOI after management fees grew 7.3 percent and REVPOR (revenue per occupied room) grew 3.2 percent for these same-store communities in the first quarter of 2013 compared to the first quarter of 2012.

FIRST QUARTER HIGHLIGHTS AND OTHER RECENT DEVELOPMENTS

Investments and Dispositions

  • Ventas invested approximately $200 million in ten assets in which the Company previously had a noncontrolling interest or was the tenant under a capital lease prior to the acquisition. These investments were on-campus, 100 percent leased MOBs and private pay seniors housing communities yielding approximately 6.5 percent.
  • Ventas sold assets, including loans, and received final repayment on outstanding loans for aggregate proceeds of $156 million.

Liquidity, Capital Raising, Ratings and Balance Sheet

  • In March 2013, Ventas issued and sold $758.8 million aggregate principal amount of senior notes with a weighted average interest rate of 3.6 percent and a weighted average initial maturity of 15 years and used the proceeds to repay amounts outstanding under the Company’s unsecured revolving credit facility bearing interest at LIBOR plus 110 basis points. These transactions took advantage of historically low interest rates, expanded the Company’s available liquidity, improved its ratio of fixed to floating rate debt, and extended its average maturity schedule.
  • In February, the Company repaid in full, at par, $269.9 million aggregate principal amount of its outstanding 6.25 percent senior notes due 2013, which notes were accruing interest at a GAAP (U.S. generally accepted accounting principles) rate of 1.75 percent.
  • As previously announced, Ventas established an “at-the-market” equity offering program (“ATM”) through which it may sell up to an aggregate of $750 million of its common stock. During the quarter, the Company received aggregate proceeds of approximately $5 million from sales of its common stock under this program. To date, the Company has issued 1.1 million shares under the ATM at an average sales price exceeding $74 per share for total gross proceeds of $83.7 million.
  • Standard & Poor’s Rating Services (“S&P”) improved its outlook on the Company’s corporate credit rating to “positive” in April 2013. Ventas’s senior unsecured debt is currently rated BBB+ (stable) by Fitch Ratings, Baa2 (positive) by Moody’s Investors Service and BBB (positive) by S&P.
  • The Company’s debt to total capitalization at March 31, 2013 was approximately 28 percent.
  • The Company’s net debt to Adjusted Pro Forma EBITDA (as defined herein) at March 31, 2013 was 5.3x.
  • At March 31, 2013, the Company had $165 million of borrowings outstanding under its unsecured revolving credit facility and $58 million of cash and cash equivalents. Currently, it has $3.7 million in borrowings outstanding under its unsecured revolving credit facility and approximately $58 million of cash and cash equivalents.

DIVIDENDS, PORTFOLIO UPDATE & ADDITIONAL INFORMATION

  • Ventas increased the first quarterly installment of its 2013 dividend by eight percent to $0.67 per share, which was paid on March 28, 2013.
  • The Company owned 1,215 properties for the full first quarters of 2013 and 2012 ("same-store").  Cash NOI growth for the Company's total same-store portfolio was 4.2 percent in the first quarter of 2013 compared to the first quarter of 2012.
  • As previously announced, Ventas has entered into lease renewals, new leases or sale contracts for all 89 licensed healthcare facilities leased by Kindred Healthcare, Inc. (NYSE: KND) (“Kindred”) whose lease term was up for renewal May 1, 2013. Ventas continues to expect all transactions and operating transitions to be completed during the first half of 2013. Certain of these transactions and operating transitions remain subject to customary closing conditions, including regulatory approval. Accordingly, there can be no assurance that the transactions will be completed or that the expected operating transitions will occur.
  • The 173 skilled nursing facilities (“SNFs”) and long-term acute care hospitals (“LTACs”) currently master leased by the Company to Kindred produced EBITDARM (earnings before interest, taxes, depreciation, amortization, rent and management fees) to actual cash rent coverage of 2.0x for the trailing 12-month period ended December 31, 2012 (the latest date available).
  • Supplemental information regarding the Company can be found on the Company’s website under the “Investor Relations” section or at www.ventasreit.com/investor-relations/financial-information/supplemental-information.

VENTAS REAFFIRMS 2013 NORMALIZED FFO PER DILUTED SHARE GUIDANCE OF $3.99 TO $4.07

Ventas continues to expect (a) its 2013 normalized FFO per diluted share, excluding the impact of unannounced acquisitions, divestitures and capital transactions, to range between $3.99 and $4.07 and (b) its 2013 NOI for its total Atria- and Sunrise-managed seniors housing operating portfolio to range between $430 million and $440 million, representing approximately five percent to eight percent same-store NOI growth.

Excluding non-cash items from normalized FFO (projected to be $0.12 per diluted share), computed consistent with prior periods, the midpoint of the Company’s guidance range constitutes approximately nine percent per share growth in 2013. A reconciliation of the Company’s guidance, and the non-cash items, to the Company’s projected GAAP earnings is included elsewhere in this press release.

The Company’s guidance is based upon previously announced assumptions and other assumptions, which are subject to change and many of which are outside the control of the Company. If actual results vary from these assumptions, the Company’s expectations may change. There can be no assurance that the Company will achieve these results. The Company may from time to time update its publicly announced guidance, but it is not obligated to do so.

FIRST QUARTER CONFERENCE CALL

Ventas will hold a conference call to discuss this earnings release today at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call is (617) 213-8055. The participant passcode is “Ventas.” The conference call is being webcast live by Thomson Reuters and can be accessed at the Company’s website at www.ventasreit.com or at www.earnings.com. A replay of the webcast will be available today online, or by calling (617) 801-6888, passcode 92222718, beginning at approximately 12:00 p.m. Eastern Time and will be archived for 28 days.

Ventas, Inc., an S&P 500 company, is a leading healthcare real estate investment trust. Its diverse portfolio of more than 1,400 assets in 47 states (including the District of Columbia) and two Canadian provinces consists of seniors housing communities, skilled nursing facilities, hospitals, medical office buildings and other properties. Through its Lillibridge subsidiary, Ventas provides management, leasing, marketing, facility development and advisory services to highly rated hospitals and health systems throughout the United States. More information about Ventas and Lillibridge can be found at www.ventasreit.com and www.lillibridge.com.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s or its tenants’, operators’, managers’ or borrowers’ expected future financial condition, results of operations, cash flows, funds from operations, dividends and dividend plans, financing opportunities and plans, capital markets transactions, business strategy, budgets, projected costs, operating metrics, capital expenditures, competitive positions, acquisitions, investment opportunities, dispositions, merger integration, growth opportunities, expected lease income, continued qualification as a real estate investment trust (“REIT”), plans and objectives of management for future operations and statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions are forward-looking statements. These forward-looking statements are inherently uncertain, and actual results may differ from the Company’s expectations. The Company does not undertake a duty to update these forward-looking statements, which speak only as of the date on which they are made.

The Company’s actual future results and trends may differ materially from expectations depending on a variety of factors discussed in the Company’s filings with the Securities and Exchange Commission. These factors include without limitation: (a) the ability and willingness of the Company’s tenants, operators, borrowers, managers and other third parties to satisfy their obligations under their respective contractual arrangements with the Company, including, in some cases, their obligations to indemnify, defend and hold harmless the Company from and against various claims, litigation and liabilities; (b) the ability of the Company’s tenants, operators, borrowers and managers to maintain the financial strength and liquidity necessary to satisfy their respective obligations and liabilities to third parties, including without limitation obligations under their existing credit facilities and other indebtedness; (c) the Company’s success in implementing its business strategy and the Company’s ability to identify, underwrite, finance, consummate and integrate diversifying acquisitions and investments, including investments in different asset types and outside the United States; (d) macroeconomic conditions such as a disruption of or lack of access to the capital markets, changes in the debt rating on U.S. government securities, default or delay in payment by the United States of its obligations, and changes in the federal budget resulting in the reduction or nonpayment of Medicare or Medicaid reimbursement rates; (e) the nature and extent of future competition; (f) the extent of future or pending healthcare reform and regulation, including cost containment measures and changes in reimbursement policies, procedures and rates; (g) increases in the Company’s borrowing costs as a result of changes in interest rates and other factors; (h) the ability of the Company’s operators and managers, as applicable, to comply with laws, rules and regulations in the operation of the Company’s properties, to deliver high-quality services, to attract and retain qualified personnel and to attract residents and patients; (i) changes in general economic conditions or economic conditions in the markets in which the Company may, from time to time, compete, and the effect of those changes on the Company’s revenues, earnings and funding sources; (j) the Company’s ability to pay down, refinance, restructure or extend its indebtedness as it becomes due; (k) the Company’s ability and willingness to maintain its qualification as a REIT due to economic, market, legal, tax or other considerations; (l) final determination of the Company’s taxable net income for the year ended December 31, 2012 and the year ending December 31, 2013; (m) the ability and willingness of the Company’s tenants to renew their leases with the Company upon expiration of the leases, the Company’s ability to reposition its properties on the same or better terms in the event of nonrenewal or in the event the Company exercises its right to replace an existing tenant, and obligations, including indemnification obligations, the Company may incur in connection with the replacement of an existing tenant; (n) risks associated with the Company’s senior living operating portfolio, such as factors that can cause volatility in the Company’s operating income and earnings generated by those properties, including without limitation national and regional economic conditions, costs of food, materials, energy, labor and services, employee benefit costs, insurance costs and professional and general liability claims, and the timely delivery of accurate property-level financial results for those properties; (o) changes in U.S. and Canadian currency exchange rates; (p) year-over-year changes in the Consumer Price Index and the effect of those changes on the rent escalators contained in the Company’s leases, including the rent escalators for two of the Company’s master lease agreements with Kindred, and the Company’s earnings; (q) the Company’s ability and the ability of its tenants, operators, borrowers and managers to obtain and maintain adequate property, liability and other insurance from reputable, financially stable providers; (r) the impact of increased operating costs and uninsured professional liability claims on the liquidity, financial condition and results of operations of the Company’s tenants, operators, borrowers and managers, and the ability of the Company’s tenants, operators, borrowers and managers to accurately estimate the magnitude of those claims; (s) risks associated with the Company’s MOB portfolio and operations, including the Company’s ability to successfully design, develop and manage MOBs, to accurately estimate its costs in fixed fee-for-service projects and to retain key personnel; (t) the ability of the hospitals on or near whose campuses the Company’s MOBs are located and their affiliated health systems to remain competitive and financially viable and to attract physicians and physician groups; (u) the Company’s ability to build, maintain and expand its relationships with existing and prospective hospital and health system clients; (v) risks associated with the Company’s investments in joint ventures and unconsolidated entities, including its lack of sole decision-making authority and its reliance on its joint venture partners’ financial condition; (w) the impact of market or issuer events on the liquidity or value of the Company’s investments in marketable securities; (x) merger and acquisition activity in the healthcare industry resulting in a change of control of one or more of the Company’s tenants, operators, borrowers or managers or significant changes in the senior management of the Company’s tenants, operators, borrowers or managers; and (y) the impact of litigation or any financial, accounting, legal or regulatory issues that may affect the Company or its tenants, operators, borrowers or managers. Many of these factors are beyond the control of the Company and its management.

CONSOLIDATED BALANCE SHEETS
As of March 31, 2013, December 31, 2012, September 30, 2012, June 30, 2012 and March 31, 2012
(In thousands, except per share amounts)
         
March 31, December 31, September 30, June 30, March 31,
2013 2012 2012 2012 2012
Assets
Real estate investments:
Land and improvements $ 1,764,208 $ 1,772,417 $ 1,754,826 $ 1,744,752 $ 1,616,947
Buildings and improvements 16,977,860 16,920,821 16,552,534 16,181,392 15,329,730
Construction in progress 72,714 70,665 93,992 133,890 85,418
Acquired lease intangibles 984,023   981,704   965,500   920,116   799,136  
19,798,805 19,745,607 19,366,852 18,980,150 17,831,231
Accumulated depreciation and amortization (2,803,068 ) (2,634,075 ) (2,447,175 ) (2,256,197 ) (2,084,212 )
Net real estate property 16,995,737 17,111,532 16,919,677 16,723,953 15,747,019
Secured loans receivable, net 490,107 635,002 215,775 213,193 222,218
Investments in unconsolidated entities 94,257   95,409   90,992   104,636   106,086  
Net real estate investments 17,580,101 17,841,943 17,226,444 17,041,782 16,075,323
Cash and cash equivalents 57,690 67,908 58,530 52,803 53,224
Escrow deposits and restricted cash 99,225 105,913 76,908 114,883 114,420
Deferred financing costs, net 54,079 42,551 25,426 25,750 26,601
Other assets 915,826   921,685   1,053,591   987,043   919,391  
Total assets $ 18,706,921   $ 18,980,000   $ 18,440,899   $ 18,222,261   $ 17,188,959  
 
Liabilities and equity
Liabilities:
Senior notes payable and other debt $ 8,295,908 $ 8,413,646 $ 7,494,774 $ 7,204,727 $ 6,430,364
Accrued interest 58,086 47,565 56,326 47,842 58,041
Accounts payable and other liabilities 910,692 995,156 1,049,043 1,059,385 1,060,647
Deferred income taxes 261,122   259,715   265,116   271,066   271,408  
Total liabilities 9,525,808 9,716,082 8,865,259 8,583,020 7,820,460
 
Redeemable OP unitholder and noncontrolling interests 194,302 174,555 113,908 116,635 106,264
 
Commitments and contingencies
 
Equity:
Ventas stockholders' equity:

Preferred stock, $1.00 par value; 10,000 shares authorized, unissued

Common stock, $0.25 par value; 295,823, 295,565, 295,534, 295,370 and 289,027 shares issued at March 31, 2013, December 31, 2012, September 30, 2012, June 30, 2012 and March 31, 2012, respectively

73,969 73,904 73,896 73,855 72,273
Capital in excess of par value 9,904,694 9,920,962 9,941,030 9,932,839 9,591,880
Accumulated other comprehensive income 21,828 23,354 23,626 21,404 23,926
Retained earnings (deficit) (861,434 ) (777,927 ) (680,888 ) (609,487 ) (500,808 )

Treasury stock, 3,736, 3,699, 0, 0 and 10 shares at March 31, 2013, December 31, 2012, September 30, 2012, June 30, 2012 and March 31, 2012, respectively

(223,709 ) (221,165 )     (536 )
Total Ventas stockholders’ equity 8,915,348 9,019,128 9,357,664 9,418,611 9,186,735
Noncontrolling interest 71,463   70,235   104,068   103,995   75,500  
Total equity 8,986,811   9,089,363   9,461,732   9,522,606   9,262,235  
Total liabilities and equity $ 18,706,921   $ 18,980,000   $ 18,440,899   $ 18,222,261   $ 17,188,959  

 
CONSOLIDATED STATEMENTS OF INCOME
For the three months ended March 31, 2013 and 2012
(In thousands, except per share amounts)
   
 
2013 2012
Revenues:
Rental income:
Triple-net leased $ 213,763 $ 203,575
Medical office buildings 111,146   63,965  
324,909 267,540
Resident fees and services 339,170 285,193
Medical office building and other services revenue 3,648 5,608
Income from loans and investments 16,103 8,036
Interest and other income 1,038   47  
Total revenues 684,868 566,424
 
Expenses:
Interest 79,600 68,130
Depreciation and amortization 179,017 160,421
Property-level operating expenses:
Senior living 230,908 195,134
Medical office buildings 36,541   20,703  
267,449 215,837
Medical office building services costs 1,639 2,988
General, administrative and professional fees 28,774 22,198
Loss on extinguishment of debt, net 29,544
Merger-related expenses and deal costs 4,262 7,981
Other 4,587   1,576  
Total expenses 565,328   508,675  
 

Income before income from unconsolidated entities, income taxes, discontinued operations and noncontrolling interest

119,540 57,749
Income from unconsolidated entities 929 317
Income tax expense (1,744 ) (11,338 )
Income from continuing operations 118,725 46,728
Discontinued operations (5,627 ) 43,364  
Net income 113,098 90,092
Net income (loss) attributable to noncontrolling interest 905   (534 )
Net income attributable to common stockholders $ 112,193   $ 90,626  
 
Earnings per common share:
Basic:

Income from continuing operations attributable to common stockholders

$ 0.40 $ 0.16
Discontinued operations (0.02 ) 0.15  
Net income attributable to common stockholders $ 0.38   $ 0.31  
Diluted:

Income from continuing operations attributable to common stockholders

$ 0.40 $ 0.16
Discontinued operations (0.02 ) 0.15  
Net income attributable to common stockholders $ 0.38   $ 0.31  
 
Weighted average shares used in computing earnings per common share:
Basic 291,455 288,375
Diluted 293,924 290,813
 
Dividends declared per common share $ 0.67 $ 0.62

 
QUARTERLY CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share amounts)
         
2013 First 2012 Quarters
Quarter Fourth Third Second First
 
Revenues:
Rental income:
Triple-net leased $ 213,763 $ 207,761 $ 208,211 $ 204,898 $ 203,575
Medical office buildings 111,146   108,951   100,814   89,110   63,965  
324,909 316,712 309,025 294,008 267,540
Resident fees and services 339,170 321,933 316,560 303,437 285,193
Medical office building and other services revenue 3,648 3,950 4,544 6,639 5,608
Income from loans and investments 16,103 14,690 9,035 8,152 8,036
Interest and other income 1,038   665   330   65   47  
Total revenues 684,868 657,950 639,494 612,301 566,424
 
Expenses:
Interest 79,600 76,364 74,555 72,979 68,130
Depreciation and amortization 179,017 182,894 189,277 187,705 160,421
Property-level operating expenses:
Senior living 230,908 222,551 216,306 208,066 195,134
Medical office buildings 36,541   39,684   36,144   29,621   20,703  
267,449 262,235 252,450 237,687 215,837
Medical office building services costs 1,639 1,569 1,487 3,839 2,988
General, administrative and professional fees 28,774 23,022 26,867 26,423 22,198
(Gain) loss on extinguishment of debt, net (699 ) (1,194 ) 9,989 29,544
Merger-related expenses and deal costs 4,262 13,617 4,917 36,668 7,981
Other 4,587   1,887   1,966   1,510   1,576  
Total expenses 565,328   560,889   550,325   576,800   508,675  
 

Income before income from unconsolidated entities, income taxes, discontinued operations and noncontrolling interest

119,540 97,061 89,169 35,501 57,749
Income from unconsolidated entities 929 249 17,074 514 317
Income tax (expense) benefit (1,744 ) 3,555   8,886   5,179   (11,338 )
Income from continuing operations 118,725 100,865 115,129 41,194 46,728
Discontinued operations (5,627 ) (14,739 ) (3,308 ) 32,542   43,364  
Net income 113,098 86,126 111,821 73,736 90,092
Net income (loss) attributable to noncontrolling interest 905   (141 ) (61 ) (289 ) (534 )
Net income attributable to common stockholders $ 112,193   $ 86,267   $ 111,882   $ 74,025   $ 90,626  
 
Earnings per common share:
Basic:

Income from continuing operations attributable to common stockholders

$ 0.40 $ 0.34 $ 0.39 $ 0.15 $ 0.16

Discontinued operations

(0.02 ) (0.05 ) (0.01 )   0.11   0.15  
Net income attributable to common stockholders $ 0.38   $ 0.29   $ 0.38   $ 0.26   $ 0.31  
Diluted:

Income from continuing operations attributable to common stockholders

$ 0.40 $ 0.34 $ 0.39 $ 0.14 $ 0.16
Discontinued operations (0.02 ) (0.05 ) (0.01 ) 0.11   0.15  
Net income attributable to common stockholders $ 0.38   $ 0.29   $ 0.38   $ 0.25   $ 0.31  
 

Weighted average shares used in computing earnings per common share:

Basic 291,455 294,704 294,928 290,170 288,375
Diluted 293,924 297,089 297,407 292,592 290,813

 
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the three months ended March 31, 2013 and 2012
(In thousands)
  2013   2012
Cash flows from operating activities:
Net income $ 113,098 $ 90,092
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including amounts in discontinued operations) 186,943 164,636
Amortization of deferred revenue and lease intangibles, net (3,310 ) (5,160 )
Other non-cash amortization (5,329 ) (10,108 )
Change in fair value of financial instruments 25 33
Stock-based compensation 5,662 4,834
Straight-lining of rental income, net (7,865 ) (4,890 )
Loss on extinguishment of debt, net 29,544
Gain on real estate dispositions, net (including amounts in discontinued operations) (477 ) (40,233 )
(Gain) loss on real estate loan investments (340 ) 559
Income tax expense (including amounts in discontinued operations) 1,744 11,305
Loss (income) from unconsolidated entities 312 (317 )
Gain on re-measurement of equity interest upon acquisition, net (1,241 )
Other 2,880 3,049
Changes in operating assets and liabilities:
(Increase) decrease in other assets (10,459 ) 1,275
Increase in accrued interest 10,530 20,452
Decrease in accounts payable and other liabilities (61,868 ) (20,110 )
Net cash provided by operating activities 230,305 244,961
Cash flows from investing activities:
Net investment in real estate property (56,175 ) (500 )
Purchase of noncontrolling interest (3,186 )
Investment in loans receivable (2,789 ) (22,473 )
Proceeds from real estate disposals 11,250 8,847
Proceeds from loans receivable 146,394 17,244
Funds held in escrow for future development expenditures 5,440
Development project expenditures (21,588 ) (31,274 )
Capital expenditures (19,795 ) (10,019 )
Other (78 ) (2,137 )
Net cash provided by (used in) investing activities 59,473 (40,312 )
Cash flows from financing activities:
Net change in borrowings under revolving credit facility (375,916 ) (382,398 )
Proceeds from debt 916,871 667,330
Repayment of debt (635,793 ) (298,801 )
Payment of deferred financing costs (13,808 ) (1,793 )
Issuance of common stock, net 5,050
Cash distribution to common stockholders (195,700 ) (179,253 )
Cash distribution to redeemable OP unitholders (1,151 ) (1,112 )
Purchases of redeemable OP units (108 ) (233 )
Distributions to noncontrolling interest (1,450 ) (1,592 )
Other 2,058   565  
Net cash used in financing activities (299,947 ) (197,287 )
Net (decrease) increase in cash and cash equivalents (10,169 ) 7,362
Effect of foreign currency translation on cash and cash equivalents (49 ) 55
Cash and cash equivalents at beginning of period 67,908   45,807  
Cash and cash equivalents at end of period $ 57,690   $ 53,224  
 
Supplemental schedule of non-cash activities:
Assets and liabilities assumed from acquisitions:
Real estate investments $ 8,839 $ 54,881
Utilization of funds held for an Internal Revenue Code Section 1031 exchange (37,799 )
Other assets acquired 668 (5,126 )
Debt assumed 17,734
Other liabilities 6,422 (6,989 )
Deferred income tax liability 1,532
Noncontrolling interests 1,553 (3,115 )
Equity issued 4,326
Debt transferred on the sale of assets 14,535

 
QUARTERLY CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
         
2013 First 2012 Quarters
Quarter Fourth Third Second First
Cash flows from operating activities:
Net income $ 113,098 $ 86,126 $ 111,821 $ 73,736 $ 90,092
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization (including amounts in discontinued operations) 186,943 201,748 196,622 201,769 164,636
Amortization of deferred revenue and lease intangibles, net (3,310 ) (4,153 ) (4,136 ) (3,669 ) (5,160 )
Other non-cash amortization (5,329 ) (8,617 ) (10,141 ) (11,077 ) (10,108 )
Change in fair value of financial instruments 25 (52 ) 58 60 33
Stock-based compensation 5,662 4,255 5,443 6,252 4,834
Straight-lining of rental income, net (7,865 ) (7,330 ) (6,242 ) (5,580 ) (4,890 )
(Gain) loss on extinguishment of debt, net (699 ) (1,194 ) 9,989 29,544
Gain on real estate dispositions, net (including amounts in discontinued operations) (477 ) (1,804 ) (357 ) (38,558 ) (40,233 )
(Gain) loss on real estate loan investments (340 ) (5,789 ) 559
Income tax expense (benefit) (including amounts in discontinued operations) 1,744 (3,555 ) (8,870 ) (5,166 ) 11,305
Loss (income) from unconsolidated entities 312 (249 ) (429 ) (514 ) (317 )
Gain on re-measurement of equity interest upon acquisition, net (1,241 ) (16,645 )
Other 2,880 3,994 424 2,848 3,049
Changes in operating assets and liabilities:
(Increase) decrease in other assets (10,459 ) 15,686 (12,791 ) (414 ) 1,275
Increase (decrease) in accrued interest 10,530 (8,761 ) 8,471 (10,193 ) 20,452
(Decrease) increase in accounts payable and other liabilities (61,868 ) 12,697   (13,524 ) (3,635 ) (20,110 )
Net cash provided by operating activities 230,305 283,497 248,510 215,848 244,961
Cash flows from investing activities:
Net investment in real estate property (56,175 ) (298,153 ) (255,508 ) (898,904 ) (500 )
Purchase of private investment funds (276,419 )
Purchase of noncontrolling interest (3,186 ) (3,934 )
Investment in loans receivable (2,789 ) (422,035 ) (3,263 ) (4,787 ) (22,473 )
Proceeds from real estate disposals 11,250 73,900 66,298 8,847
Proceeds from loans receivable 146,394 8,402 1,594 15,979 17,244
Proceeds from sale or maturity of marketable securities 37,500
Funds held in escrow for future development expenditures 5,440 (28,050 )
Development project expenditures (21,588 ) (23,883 ) (29,558 ) (29,287 ) (31,274 )
Capital expenditures (19,795 ) (27,160 ) (18,458 ) (13,793 ) (10,019 )
Other (78 ) 115   40   (13 ) (2,137 )
Net cash provided by (used in) investing activities 59,473 (955,783 ) (238,855 ) (934,739 ) (40,312 )
Cash flows from financing activities:
Net change in borrowings under revolving credit facility (375,916 ) (163,983 ) 337,575 293,744 (382,398 )
Proceeds from debt 916,871 1,142,023 299,067 601,985 667,330
Repayment of debt (635,793 ) (90,023 ) (457,278 ) (346,921 ) (298,801 )
Payment of deferred financing costs (13,808 ) (19,513 ) (1,277 ) (1,187 ) (1,793 )
Issuance of common stock, net 5,050 342,469
Cash distribution to common stockholders (195,700 ) (183,306 ) (183,283 ) (182,704 ) (179,253 )
Cash distribution to redeemable OP unitholders (1,151 ) (1,088 ) (1,117 ) (1,129 ) (1,112 )
Purchases of redeemable OP units (108 ) (2,841 ) (1,149 ) (378 ) (233 )
Distributions to noncontrolling interest (1,450 ) (1,180 ) (1,128 ) (1,315 ) (1,592 )
Other 2,058   1,573   4,621   13,944   565  
Net cash (used in) provided by financing activities (299,947 ) 681,662   (3,969 ) 718,508   (197,287 )
Net (decrease) increase in cash and cash equivalents (10,169 ) 9,376 5,686 (383 ) 7,362
Effect of foreign currency translation on cash and cash equivalents (49 ) 2 40 (37 ) 55
Cash and cash equivalents at beginning of period 67,908   58,530   52,804   53,224   45,807  
Cash and cash equivalents at end of period $ 57,690   $ 67,908   $ 58,530   $ 52,804   $ 53,224  
 
Supplemental schedule of non-cash activities:
Assets and liabilities assumed from acquisitions:
Real estate investments $ 8,839 $ 84,939 $ 132,872 $ 310,002 $ 54,881
Utilization of funds held for an Internal Revenue Code Section 1031 exchange (96,204 ) (37,799 )
Other assets acquired 668 (22,159 ) 18,380 86,635 (5,126 )
Debt assumed 44,923 117,539 232,629 17,734
Other liabilities 6,422 9,707 34,045 33,628 (6,989 )
Deferred income tax liability 1,532 (1,596 ) 5,895
Noncontrolling interests 1,553 8,150 1,264 28,281 (3,115 )
Equity issued 4,326
Debt transferred on the sale of assets 14,535

               
NON-GAAP FINANCIAL MEASURES RECONCILIATION

Funds From Operations (FFO) Including and Excluding Non-Cash Items1

(Dollars in thousands, except per share amounts)
 
 

Tentative Estimates
Preliminary and
Subject to Change

Year-
Over-
Year
Growth2

2012   2013   FY2013 - Guidance  
Q1   Q2   Q3   Q4   FY   Q1   Low   High   ‘12-‘13E
 
Net income attributable to common stockholders $ 90,626 $ 74,025 $ 111,882 $ 86,267 $ 362,800 $ 112,193 $

361,190

$

428,481

Net income attributable to common stockholders per share $ 0.31

 

  $ 0.25     $ 0.38     $ 0.29     $ 1.23     $ 0.38     $

1.22

    $

1.45

 
 
Adjustments:
Depreciation and amortization on real estate assets 159,519 186,704 188,025 181,626 715,874 177,739

771,711

761,711

Depreciation on real estate assets related to noncontrolling interest

(1,511 ) (2,336 ) (2,221 ) (2,435 ) (8,503 ) (2,502 )

(8,623

)

(10,623

)

Depreciation on real estate assets related to unconsolidated entities

2,175 2,131 1,700 1,510 7,516 1,646

7,082

6,082

Gain on re-measurement of equity interest upon acquisition, net

(16,645 ) (16,645 ) (1,241 )

 

(1,241

)

 

(1,241

)

Discontinued operations:
(Gain) loss on real estate dispositions, net (40,233 ) (38,558 ) (357 ) (1,804 ) (80,952 ) (477 )

2,553

(3,447

)

Depreciation and amortization on real estate assets 4,215     14,064     7,345     18,853     44,477     7,926     9,431     9,431  
Subtotal: Funds From Operations add-backs 124,165 162,005 177,847 197,750 661,767 183,091

780,913

761,913

Subtotal: Funds From Operations add-backs per share   $ 0.43     $ 0.55     $ 0.60     $ 0.67     $ 2.25     $ 0.62     $

2.65

    $

2.58

     
Funds From Operations $ 214,791 $ 236,030 $ 289,729 $ 284,017 $ 1,024,567 $ 295,284 $

1,142,103

$

1,190,394

14 %
Funds From Operations per share   $ 0.74     $ 0.81     $ 0.97     $ 0.96     $ 3.48     $ 1.00     $ 3.87     $

4.03

    14 %
 
Adjustments:
Merger-related expenses and deal costs 7,981 36,668 4,917 13,617 63,183 4,262 20,675

10,000

Income tax expense (benefit) 11,305 (5,166 ) (8,870 ) (3,555 ) (6,286 ) 1,744 8,500 5,500
Loss (gain) on extinguishment of debt, net 29,544 9,989 (1,194 ) (699 ) 37,640 5,000 (5,000 )
Change in fair value of financial instruments 33 60 58 (52 ) 99 25

25

25

Amortization of other intangibles 256     255     256     255     1,022     256     1,522     522  
Subtotal: Normalized Funds From Operations add-backs 49,119 41,806 (4,833 ) 9,566 95,658 6,287

35,722

11,047

Subtotal: Normalized Funds From Operations add-backs per share

  $ 0.17     $ 0.14     $ (0.02 )   $ 0.03     $ 0.32     $ 0.02     $ 0.12     $

0.04

     
Normalized Funds From Operations $ 263,910 $ 277,836 $ 284,896 $ 293,583 $ 1,120,225 $ 301,571 $

1,177,825

$

1,201,441

6 %
Normalized Funds From Operations per share   $ 0.91     $ 0.95     $ 0.96     $ 0.99     $ 3.80     $ 1.03     $ 3.99     $ 4.07     6 %
 
Non-cash items included in Normalized FFO:
Amortization of deferred revenue and lease intangibles, net (5,160 ) (3,669 ) (4,136 ) (4,153 ) (17,118 ) (3,310 ) (14,549 ) (14,549 )

Other non-cash amortization, including fair market value of debt

(10,108 ) (11,077 ) (10,141 ) (8,617 ) (39,943 ) (5,329 ) (17,130 ) (17,130 )
Stock-based compensation 4,834 6,252 5,443 4,255 20,784 5,662 22,649 22,649
Straight-lining of rental income, net (4,890 )   (5,580 )   (6,242 )   (7,330 )   (24,042 )   (7,865 )   (25,016 )   (25,016 )
Subtotal: non-cash items included in Normalized FFO (15,324 ) (14,074 ) (15,076 ) (15,845 ) (60,319 ) (10,842 ) (34,046 ) (34,046 )
Subtotal: non-cash items included in Normalized
FFO per share   $ (0.05 )   $ (0.05 )   $ (0.05 )   $ (0.05 )   $ (0.20 )   $ (0.04 )   $ (0.12 )   $ (0.12 )    
Normalized FFO, excluding non-cash items $ 248,586 $ 263,762 $ 269,820 $ 277,738 $ 1,059,906 $ 290,729 $

1,143,779

$

1,167,395

9

%
Normalized FFO, excluding non-cash items per share   $ 0.85     $ 0.90     $ 0.91     $ 0.93     $ 3.60     $ 0.99     $ 3.87     $ 3.95     9 %
 
Weighted average diluted shares 290,813 292,592 297,407 297,089 294,488 293,924

295,194

   

295,194

 
 
1 Totals and per share amounts may not add due to rounding. Per share quarterly amounts may not add to annual per share amounts due to material changes in the Company’s weighted average diluted share count, if any.
2 2012-2013E growth assumes the midpoint of 2013 guidance.
 

Historical cost accounting for real estate assets implicitly assumes that the value of real estate assets diminishes predictably over time. Since real estate values instead have historically risen or fallen with market conditions, many industry investors have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient by themselves. To overcome this problem, the Company considers FFO and normalized FFO appropriate measures of operating performance of an equity REIT. Moreover, the Company believes that normalized FFO provides useful information because it allows investors, analysts and Company management to compare the Company’s operating performance to the operating performance of other real estate companies and between periods on a consistent basis without having to account for differences caused by unanticipated items such as transactions and litigation.

The Company uses the NAREIT definition of FFO. NAREIT defines FFO as net income, computed in accordance with GAAP, excluding gains (or losses) from sales of real estate property, including gain on re-measurement of equity method investments, and impairment write-downs of depreciable real estate, plus real estate depreciation and amortization and after adjustments for unconsolidated partnerships and joint ventures. Adjustments for unconsolidated partnerships and joint ventures will be calculated to reflect FFO on the same basis. The Company defines normalized FFO as FFO excluding the following income and expense items (which may be recurring in nature): (a) net gains on the sales of real property assets, including gain on re-measurement of equity method investments; (b) merger-related costs and expenses, including amortization of intangibles and transition and integration expenses, and deal costs and expenses, including expenses and recoveries relating to acquisition lawsuits; (c) the impact of any expenses related to asset impairment and valuation allowances, the write-off of unamortized deferred financing fees, or additional costs, expenses, discounts, make-whole payments, penalties or premiums incurred as a result of early retirement or payment of the Company’s debt; (d) the non-cash effect of income tax benefits or expenses and derivative transactions that have non-cash mark-to-market impacts on the Company’s income statement; (e) the impact of future acquisitions or divestitures (including pursuant to tenant options to purchase) and capital transactions; (f) the financial impact of contingent consideration; (g) charitable donations made to the Ventas Charitable Foundation; and (h) gains and losses for non-operational foreign currency hedge agreements and changes in the fair value of financial instruments.

FFO and normalized FFO presented herein may not be identical to FFO and normalized FFO presented by other real estate companies due to the fact that not all real estate companies use the same definitions. FFO and normalized FFO should not be considered as alternatives to net income (determined in accordance with GAAP) as indicators of the Company’s financial performance or as alternatives to cash flow from operating activities (determined in accordance with GAAP) as measures of the Company’s liquidity, nor are FFO and normalized FFO necessarily indicative of sufficient cash flow to fund all of the Company’s needs. The Company believes that in order to facilitate a clear understanding of the consolidated historical operating results of the Company, FFO and normalized FFO should be examined in conjunction with net income as presented elsewhere herein.

 

NON-GAAP FINANCIAL MEASURES RECONCILIATION

Net Debt to Adjusted Pro Forma EBITDA

 

The following information considers the pro forma effect on net income, interest and depreciation of the Company’s investments and other capital transactions that were completed during the three months ended March 31, 2013, as if the transactions had been consummated as of the beginning of the period. The following table illustrates net debt to pro forma earnings before interest, taxes, depreciation and amortization (including non-cash stock-based compensation expense), excluding gains or losses on extinguishment of debt, merger-related expenses and deal costs, net gains on real estate activity and changes in the fair value of financial instruments (including amounts in discontinued operations) (“Adjusted Pro Forma EBITDA”) (dollars in thousands):

 
Net income attributable to common stockholders $ 112,193
Pro forma adjustments for current period investments, capital
transactions and dispositions (5,501 )
Pro forma net income for the three months ended March 31, 2013

 

106,692
Add back:
Pro forma interest (including discontinued operations) 81,324
Pro forma depreciation and amortization (including discontinued operations) 187,297
Stock-based compensation 5,662
Gain on real estate dispositions, net (477 )
Gain on re-measurement of equity interest upon acquisition, net (1,241 )
Income tax expense 1,744
Change in fair value of financial instruments 25
Other taxes 1,149
Merger-related expenses and deal costs 4,262  
Adjusted Pro Forma EBITDA $ 386,437  
Adjusted Pro Forma EBITDA annualized $ 1,545,748  
 
 
As of March 31, 2013:
Debt $ 8,295,908
Cash, including cash escrows pertaining to debt (97,585 )
Net debt $ 8,198,323  
 
Net debt to Adjusted Pro Forma EBITDA 5.3   x
 

 
NON-GAAP FINANCIAL MEASURES RECONCILIATION
NOI by Segment
(In thousands)
   
2013 First 2012 Quarters
Quarter Fourth   Third   Second   First
Revenues
 
Triple-Net
Triple-Net Rental Income $ 213,763 $ 207,761 $ 208,211 $ 204,898 $ 203,575
 
Medical Office Buildings
Medical Office - Stabilized

102,450

100,027 92,458

80,336

56,251
Medical Office - Lease up 8,696   8,924   8,356   8,774   7,714
Total Medical Office Buildings - Rental Income

111,146

  108,951   100,814  

89,110

  63,965
Total Rental Income

324,909

316,712 309,025

294,008

267,540
 
Medical Office Building Services Revenue 2,537   2,840   3,434   5,529   4,499
Total Medical Office Buildings - Revenue

113,683

111,791 104,248

94,639

68,464
 
Triple-Net Services Revenue 1,111   1,110   1,110   1,110   1,109
Total Medical Office Building and Other Services Revenue 3,648 3,950 4,544 6,639 5,608
 
Seniors Housing Operating
Seniors Housing - Stabilized 326,880 309,251 296,509 283,214 271,396
Seniors Housing - Lease up 11,548 11,939 19,311 19,491 13,078
Seniors Housing - Other 742   743   740   732   719
Total Resident Fees and Services 339,170 321,933 316,560 303,437 285,193
 
Non-Segment Income from Loans and Investments 16,103   14,690   9,035   8,152   8,036
Total Revenues, excluding Interest and Other Income

683,830

657,285 639,164

612,236

566,377
 
Property-Level Operating Expenses
 
Medical Office Buildings
Medical Office - Stabilized 33,723 36,360 32,981 26,401 17,845
Medical Office - Lease up 2,818   3,324   3,163   3,220   2,858
Total Medical Office Buildings 36,541 39,684 36,144 29,621 20,703
 
Seniors Housing Operating
Seniors Housing - Stabilized 222,362 212,781 202,045 192,640 184,749
Seniors Housing - Lease up 7,933 9,190 13,631 13,787 9,795
Seniors Housing - Other 613   580   630   1,639   590
Total Seniors Housing 230,908   222,551   216,306   208,066   195,134
Total Property-Level Operating Expenses 267,449 262,235 252,450 237,687 215,837
 
Medical Office Building Services Costs 1,639 1,569 1,487 3,839 2,988
 
Net Operating Income
 
Triple-Net
Triple-Net Properties 213,763 207,761 208,211 204,898 203,575
Triple-Net Services Revenue 1,111   1,110   1,110   1,110   1,109
Total Triple-Net 214,874 208,871 209,321 206,008 204,684
 
Medical Office Buildings
Medical Office - Stabilized

68,727

63,667 59,477

53,935

38,406
Medical Office - Lease up 5,878 5,600 5,193 5,554 4,856
Medical Office Buildings Services 898   1,271   1,947   1,690   1,511
Total Medical Office Buildings

75,503

70,538 66,617

61,179

44,773
 
Seniors Housing Operating
Seniors Housing - Stabilized 104,518 96,470 94,464 90,574 86,647
Seniors Housing - Lease up 3,615 2,749 5,680 5,704 3,283
Seniors Housing - Other 129   163   110   (907 ) 129
Total Seniors Housing 108,262 99,382 100,254 95,371 90,059
Non-Segment 16,103   14,690   9,035   8,152   8,036
Net Operating Income $

414,742

  $ 393,481   $ 385,227   $

370,710

  $ 347,552

 
NON-GAAP FINANCIAL MEASURES RECONCILIATION

Total Same-Store Portfolio NOI

(Dollars in thousands)
 
For the Three Months Ended
March 31,
2013   2012
 
Net Operating Income $

414,742

$ 347,552
 
Less:
NOI Not Included in Same-Store 44,914 515
Straight-Lining of Rental Income 7,888 4,786
Non-Cash Rental Income 2,856 4,269
Non-Segment NOI 18,112   10,656  
73,770   20,226  
 
Same-Store Cash NOI $

340,972

  $ 327,326  
 
Percentage Increase 4.2 %
 

Click here to subscribe to Mobile Alerts for Ventas, Inc.



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today